KBC Group NV

Position in INSM — INSMED Inc

CIK 1411133 Brussels, C9

Position in INSM

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$6,106,981

+$187,360 QoQ

Shares Held

37,347

+9.8% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

KBC Group NV holds $172,610,851 across 111 Biotechnology names. INSM ranks #7 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,208	$56,803,459
2	REGN	Regeneron Pharmaceuticals, Inc.	38,473	$29,725,778
3	JAZZ	Jazz Pharmaceuticals plc	102,199	$19,320,720
4	XENE	Xenon Pharmaceuticals Inc.	129,010	$7,501,931
5	BMRN	Biomarin Pharmaceutical Inc	127,194	$7,185,189
6	ALNY	Alnylam Pharmaceuticals, Inc.	20,524	$6,790,774
7	INSM	INSMED Inc This page	37,347	$6,106,981
8	CRSP	CRISPR Therapeutics AG	116,847	$5,558,411

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,106,981	37,347	+9.8%	Shares	Defined	2026-05-07
2025-12-31	$5,919,621	34,013	+253.7%	Shares	Defined	2026-01-26
2025-09-30	$1,384,944	9,617	+93.3%	Shares	Defined	2026-01-20
2025-06-30	$500,784	4,976	-34.1%	Shares	Defined	2025-08-08
2025-03-31	$576,065	7,551	+9.9%	Shares	Defined	2025-04-25
2024-12-31	$474,511	6,873	+59.5%	Shares	Defined	2025-01-22
2024-09-30	$314,630	4,310	+20.4%	Shares	Defined	2024-11-06
2024-06-30	$239,860	3,580	+12.8%	Shares	Defined	2024-07-17
2024-03-31	$86,137	3,175	0.0%	Shares	Defined	2024-05-08
2023-12-31	$98,393	3,175	0.0%	Shares	Defined	2024-02-13
2023-09-30	$80,168	3,175	—	Shares	Defined	2024-02-15
No filing history on record for this holder in this stock.